Synonyms: TFT | trifluorothymidine
trifluridine is an approved drug (Japan, FDA (2015), EMA (2016))
Compound class:
Synthetic organic
Comment: Trifluridine was originally approved by the US FDA in 1980, and was used for its antiviral effects (marketed as Vitroptic®). The drug is now being investigated for its antineoplastic (cytotoxic) effect.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes. Japan (2015) | FDA (2015) | EMA (2016) |
IUPAC Name ![]() |
1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione |
International Nonproprietary Names ![]() |
|
INN number | INN |
4146 | trifluridine |
Synonyms ![]() |
TFT | trifluorothymidine |
Database Links ![]() |
|
ChEMBL Ligand | CHEMBL1129 |
DrugBank Ligand | DB00432 |
DrugCentral Ligand | 2743 |
GtoPdb PubChem SID | 252166897 |
PubChem CID | 6256 |
Search Google for chemical match using the InChIKey | VSQQQLOSPVPRAZ-RRKCRQDMSA-N |
Search Google for chemicals with the same backbone | VSQQQLOSPVPRAZ |
Search PubMed clinical trials | trifluridine |
Search PubMed titles | trifluridine |
Search PubMed titles/abstracts | trifluridine |
UniChem Compound Search for chemical match using the InChIKey | VSQQQLOSPVPRAZ-RRKCRQDMSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | VSQQQLOSPVPRAZ-RRKCRQDMSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Trifluridine (links to external site)
Cat. No. HY-A0061 |